Prior research establishing that bone interacts in coordination with the bone marrow
microenvironment (BMME) to regulate hematopoietic homeostasis was largely based on …

Multiple Myeloma (MM) is a plasma cell cancer with high mortality and morbidity rates. Its
incidence rate has increased by 143% since 1975. Adipokines, cytokines, chemokines, and …

Background Incidence, manifestations and case-fatality rate (CFR) of invasive
pneumococcal disease (IPD) vary with age and comorbidities. New vaccines, changing age …

Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of
plasma cells. The incidence of MM worldwide is increasing with greater than 140 000 …

Monoclonal gammopathy of undetermined significance (MGUS) is of considerable clinical
importance to primary care physicians given its high prevalence in the general population …

Monoclonal immunoglobulins are markers of plasma cell proliferative diseases and have
been described as the first (and perhaps best) serological tumor marker. The unique …

Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic plasma
cell disorder occurring in 4.2% of adults> 50 years of age, which can progress into …

Background: Technetium-99 m pyrophosphate protocols for transthyretin cardiac
amyloidosis diagnosis have variably used 1-and 3-hour imaging time points. We …

Results We retrospectively reviewed kidney biopsies from patients diagnosed with fibrillary
GN or suspected fibrillary GN between 1997 and 2017 (n= 266, 65% female, median age …

Monoclonal gammopathies (MG) are defined by increased proliferation of clonal plasma
cells, resulting in a detectable abnormality called monoclonal component or M-protein …